Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 164 active Myelodysplastic Syndrome trials
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Study Type: Observational
MBG453 in Lower Risk MDS
Study Type: Interventional Phase 2
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Study Type: Observational
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
Study Type: Interventional Phase 2
There are 164 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now